Assessment of Prevalence of Chronic Kidney Disease and Its Predisposing Factors in Kerman City

Abstract

Background: Chronic kidney disease (CKD) is a prevalent, progressive, and treatable disease. However, lack of enough data about its prevalence in Iran is a major obstacle for its early detection. In order to determine the prevalence of the disease in the country, it is necessary to conduct epidemiologic studies especially on populations with ethnic diversity; hence, this study aimed at determining the prevalence of CKD and its predisposing factors in an adult population aged 15 to 75 years old in Kerman city. Methods: This cross-sectional study was conducted on 988 adults aged 15 to 75 years in Kerman city, during year 2010. We collected data on the status of hypertension (HTN) and Diabetes Mellitus (DM) in all participants. Moreover, height, weight, and blood pressure of all participants were measured and a blood sample was taken for laboratory tests. In addition, a morning urine sample was taken to detect microalbuminuria and measure protein, and creatinine. Patients’ glomerular filtration rate (GFR) was calculated using modification of diet in renal disease (MDRD) formula, and the stage of the chronic kidney disease (CKD) was determined. Results: Of all the participants, 58% were female and the mean age (SD) of participants was 45 ± 16 years. Considering participants’ body mass index (BMI), 37% were overweight and 18% were obese. The prevalence of HTN and DM were 20% and 14%, respectively. Mean GFR (SD) was 67 ± 20 mL/min/1.73 m2. Overall, 91% of the participants were affected by some degree of CKD (stage 1:5%; stage 2: 55.1%; stage 3: 30.5%; stage 4: 0.4%). Prevalence of CKD that was defined through GFR 0.05). Conclusions: The findings of the present study showed that 91% of the adult population living in Kerman city was affected by some degrees of CKD and more than one-third were at stages 3 or 4. Prevalence of CKD that was defined through GFR < 60 cc/min was 30.9%. Since early detection of CKD could help adopt preventive measures and interventions, and prevent disease progression, policy makers must pay special attention to preventive programs, such as programs for life style modification, and design treatment plans for different risk factors, such as HTN, DM, and dyslipidemia.